PETMED EXPRESS INC (PETS) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, PETMED EXPRESS INC's filing signal turned negative.

PetMed Express, Inc., operating under the brand PetMeds(R), is a pioneer in the pet healthcare industry, leveraging a digital-first strategy since 1996 to provide direct-to-consumer pet medications, foods, and wellness products. The company markets and sells through its websites, a customer contact center, and mobile applications, offering a broad range of branded and generic pharmaceuticals, compounded medications, and Rx foods. With a focus on convenience, price, and customer service, PetMeds partners with over 75,000 veterinarians nationwide and has served nearly twenty million pet parents across all 50 states. The company is expanding its offerings to an omnichannel model, integrating its brands, PetMeds and PetCareRx, to provide a more comprehensive selection of pet health and wellness solutions.

Revenue is primarily driven by the sale of prescription medications, generic medications, over-the-counter (OTC) solutions, vitamins, supplements, prescription food, non-prescription food, and other pet supplies. The company also generates revenue from membership fees associated with its PetPlus and partner programs.